ASAN FOUNDATION
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Effect of SVV Guided Fluid Therapy on Blood Loss and Postoperative Outcomes
Not Applicable
Completed
- Conditions
- Bladder Cancer
- Interventions
- Other: crystalloidOther: colloidOther: mannitolOther: lasix
- First Posted Date
- 2015-02-27
- Last Posted Date
- 2015-12-30
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 64
- Registration Number
- NCT02373735
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
The Effect of ERAS on Pancreaticoduodenectomy
Not Applicable
Completed
- Conditions
- Periampullary Tumor
- Interventions
- Other: ERAS perioperative management
- First Posted Date
- 2015-02-26
- Last Posted Date
- 2017-06-09
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 276
- Registration Number
- NCT02372331
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Bortezomib With Steroid Pulse Therapy for Acute Cellular Rejection in Kidney Transplantation
- First Posted Date
- 2015-01-30
- Last Posted Date
- 2015-02-04
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT02351427
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Safety, Efficacy of Eglandin® in Living Donor Liver Transplanted Patient (PROVISION)
Phase 2
- Conditions
- Evidence of Liver Transplantation
- Interventions
- Drug: Eglandin
- First Posted Date
- 2015-01-29
- Last Posted Date
- 2018-07-06
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 76
- Registration Number
- NCT02350218
- Locations
- 🇰🇷
Korea, Republic of, Seoul, Korea, Republic of
Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer
Phase 2
Completed
- Conditions
- Metastatic Breast Cancer
- Interventions
- First Posted Date
- 2015-01-26
- Last Posted Date
- 2020-07-30
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 137
- Registration Number
- NCT02344550
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
The Efficacy of Urine Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome (Pilot Study)
Completed
- Conditions
- Chronic Interstitial Cystitis
- First Posted Date
- 2015-01-06
- Last Posted Date
- 2019-07-05
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT02331472
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Asan medical center Institutional review board, Seoul, Korea, Republic of
Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study)
Phase 2
- Conditions
- Hepatocellular CarcinomaMetastasis
- Interventions
- Procedure: Conventional Transarterial Chemoembolization (TACE)
- First Posted Date
- 2014-12-08
- Last Posted Date
- 2017-12-18
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 55
- Registration Number
- NCT02311205
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Bicarbonate in Patients With Out-of-hospital Cardiac Arrest
Phase 2
Completed
- Conditions
- Cardiac ArrestMetabolic Acidosis
- Interventions
- Drug: Normal saline
- First Posted Date
- 2014-12-01
- Last Posted Date
- 2022-03-25
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT02303548
Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors
- First Posted Date
- 2014-10-20
- Last Posted Date
- 2015-08-04
- Lead Sponsor
- Asan Medical Center
- Registration Number
- NCT02268435
Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast Cancer
Phase 2
Completed
- Conditions
- Metastatic Breast Cancer
- Interventions
- First Posted Date
- 2014-10-13
- Last Posted Date
- 2020-07-14
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 118
- Registration Number
- NCT02263495
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath